Annual production of 50 million injection pens, Yingjiexin's new production base starts renovation

The new base is located in Wuxi Precision Medical Industrial Park, a key biopharmaceutical industry characteristic professional park in Wuxi. The new base is a five story standalone building with a total construction area of 10000 square meters. It will create injection molding and assembly fully purified workshops, and introduce intelligent central feeding systems, intelligent warehousing systems, and multiple injection pen automated assembly lines. The renovation project of the new base is planned to be completed in the first quarter of 2025. At that time, the new base will become an intelligent, automated, and integrated R&D and production base for the aggregation of R&D design, mold processing, injection molding, and production of the 2.0 version of Yingjiexin. After the automated production line reaches full capacity, the annual production capacity of injection pens at the base will reach 50 million units.

As a medical technology enterprise specializing in the development and manufacturing of self medication systems, Yingjiexin Medical's new production base not only meets the practical needs of the company's capacity expansion, but also further relies on the new base to continuously explore cutting-edge technologies in the field of self medication systems, providing safer, more efficient, and reliable self medication device products and services for global customers.